Skip to main content

An official website of the United States government

You have 2 new alerts

Notice of Intent to Sole Source Radiopharmaceuticals

General Information

  • Contract Opportunity Type: Special Notice (Updated)
  • Updated Published Date: Sep 15, 2022 09:21 am MDT
  • Original Published Date: Sep 15, 2022 09:07 am MDT
  • Updated Response Date: Sep 15, 2022 04:00 pm MDT
  • Original Response Date: Sep 16, 2022 04:00 pm MDT
  • Inactive Policy: 15 days after response date
  • Updated Inactive Date:
  • Original Inactive Date:
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
    Fort Bliss , TX
    USA

Description

The Regional Health Contracting Office - Central intends to issue a BPA Call against established BPA W81K0020A0014 to Pharmalucence, Inc. for various Radiopharmaceuticals for William Beaumont Army Medical Center (WBAM), Fort Bliss, Texas.

This BPA Call will have a delivery period of 1 October 2022 through 30 September 2023. The North American Industrial Classification System (NAICS) code is 325412, Medical Laboratories. The Small Business Administration's size standard for NAICS 325412 is 1250 employees.

This notice is neither a request for competitive quotes. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government.

The Regional Health Contracting Office-Central intends to make a BPA Call award on or about 15 September 2022 to Pharmalucence, Inc.

Contact Information

Primary Point of Contact

Secondary Point of Contact

History